A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007
A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007
Enrolling by invitation · NCT05509855 · Registry updated 2024-11-20Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Long-Term Safety Follow-Up Study for Patients Treat With WU-CART-007 | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, T-cell acute lymphoblastic leukemia, hematologic disorder, immune system disorder, immunoproliferative disorder, leukemia, lymphatic system disorder, lymphoid leukemia, lymphoproliferative syndrome, neoplasm | Enrolling by invitation | Not stated | 2024-11-20 | NCT05509855 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Allotera Therapeutics | 3 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Children's Hospital of Philadelphia | Philadelphia | United States | 434 |
| Childrens Hospital LA | Los Angeles | United States | 2 |
| City of Hope | Duarte | United States | 238 |
| Peter MacCullam Cancer Center | Melbourne | Australia | 1 |
| Washington University | St Louis | United States | 182 |